JDD Buzz Series | GLP-1 Agonists for Hidradenitis Suppurativa
GLP-1 receptor agonists are revolutionizing the treatment of type 2 diabetes and obesity. With widespread consumer advertising campaigns, GLP-1 usage is becoming commonplace. National polls show up to one-fifth of American adults have tried GLP-1s for weight loss or to address health conditions, such as heart disease. As the understanding of GLP-1s deepens, so does …
Continue reading “JDD Buzz Series | GLP-1 Agonists for Hidradenitis Suppurativa”
Hypochlorous Acid for a Persistent Filler Nodule: A Case Report
Hyaluronic acid (HA) fillers are widely used in aesthetic medicine for facial rejuvenation, volumization, and wrinkle treatment. Noninflammatory nodules after HA filler injection are a relatively common phenomenon and a result of poor technique or a large volume bolus in one area.¹ Unlike these nodules, delayed-onset nodules (DON) occur in 0.5% of injections and can be …
Continue reading “Hypochlorous Acid for a Persistent Filler Nodule: A Case Report”
JDD December 2025 Issue Highlights | Special Focus: Immunodermatology
We’re closing out 2025 with an immunodermatology–focused issue of the Journal of Drugs in Dermatology. From incretin-based therapies for hidradenitis suppurativa (HS) to real-world data on cardiometabolic risk in inflammatory skin disease, these Editor’s Picks connect skin and systemic health with practical pearls for clinic. GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A Novel Therapeutic Approach …
Continue reading “JDD December 2025 Issue Highlights | Special Focus: Immunodermatology”
Management of Hailey-Hailey Disease With Ruxolitinib 1.5% Cream
Introduction Benign Familial Pemphigus (Hailey-Hailey Disease [HHD]) is caused by a mutation within ATP2C1, the gene encoding the calcium pump of golgi apparatuses, impacting keratinocytes’ ability to adhere to each other, resulting in acantholysis.1 Clinical presentation of HHD encompasses blisters that become erythematous plaques and fissures within flexural areas on a relapsing basis. There is …
Continue reading “Management of Hailey-Hailey Disease With Ruxolitinib 1.5% Cream”
JDD Buzz Series | The Role of Diet in Hidradenitis Suppurativa
Patients with hidradenitis suppurativa (HS) are commonly told to eat healthy to improve their disease severity. However, with so many dietary options in this day and age, what does an HS-friendly diet even look like? An article in the November Journal of Drugs in Dermatology shares research analyzing several diets and their impact on HS …
Continue reading “JDD Buzz Series | The Role of Diet in Hidradenitis Suppurativa”
JDD Buzz Series | Dermatologic Hazards of Nail Products
Concerns over nail salon safety typically focus on the dangers of UV lights or risks of a salon-acquired infection. A brief communication published in the October Journal of Drugs in Dermatology expands the thinking on the dermatologic hazards of nail products, both those used in the salon and at home. From unexpected nail changes to …
Continue reading “JDD Buzz Series | Dermatologic Hazards of Nail Products”
Pincer Nail Deformity in an African American Patient Corrected by Fractionated Carbon Dioxide Laser
Introduction Pincer nail deformity is a painful nail condition characterized by excessive transverse curvature of the nail plate that pinches the surrounding tissue.1 This condition primarily involves the toenail of the hallux and is more frequently observed in older individuals.1 Management of a pincer nail typically involves nail braces or surgical removal.1 These managements usually fall short of …
JDD Buzz Series | Trichologic Evaluations at Head Spas
A new type of spa is popping up in major U.S. cities. Head spas provide a mix of spa treatments for the scalp and hair as well as potentially therapeutic treatments for dermatologic conditions that affect the scalp. Some head spas offer consultation with a trichology professional, which may include trichoscopic imaging. Dermatologists say patients …
Continue reading “JDD Buzz Series | Trichologic Evaluations at Head Spas”
JDD Buzz Series | Insurance Coverage of Hair Loss Treatments
Dermatologists have several prescription treatment options for hair loss, including minoxidil, spironolactone, finasteride, and latanoprost. Yet despite the commonality of hair loss, insurance coverage of hair loss treatments is rare. An editorial published in the August Journal of Drugs in Dermatology assesses the differences in insurance coverage of these hair loss medications. I interviewed author …
Continue reading “JDD Buzz Series | Insurance Coverage of Hair Loss Treatments”
JDD September 2025 Issue Highlights | Special Focus: Aesthetic Treatments
Welcome to “JDD September 2025 Issue Highlights,” your guided tour through this month’s must-read studies, curated by the Journal of Drugs in Dermatology Editorial Team. This issue features a Special Focus on Aesthetic Treatments alongside cutting-edge research in novel pharmacotherapies, advanced procedural techniques, and safety assessments. Whether you’re dialing in volumization with poly-L-lactic acid or …
Continue reading “JDD September 2025 Issue Highlights | Special Focus: Aesthetic Treatments”